Bahija Jallal

This profile gathers the share dealings of Bahija Jallal across 3 companies, led by Elevance Health, Inc., Guardant Health, Inc. and Immunocore Holdings plc. The record holds 15 filings, for trades running from 1 February 2018 to 13 May 2026.

On the market, this insider has only sold: 1 sale, €313k in total. Outside the open market, there are 12 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 15 May 2026: a share grant, in Elevance Health, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.